Andrew Buchanan
16Patents
3h-index
43Co-inventors
56Inventor score
Filing activity: Jan 5, 2006 → Aug 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088736B2 | CTLA-4 protein variants | Human Necessities | 6 | Active |
| US9982061B2 | Antibodies to ticagrelor and methods of use | Chemistry; Metallurgy | 4 | Active |
| US8507656B2 | Stabilized angiopoietin-2 antibodies and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10487154B2 | Antibodies to ticagrelor and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10954308B2 | Antibodies to ticagrelor and methods of use | Chemistry; Metallurgy | 2 | Active |
| US10077319B2 | Anti-PCSK9-GLP-1 fusions and methods for use | Chemistry; Metallurgy | 2 | Active |
| US11773186B2 | Antibodies to ticagrelor and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9315571B2 | Specific binding members for NGF | Chemistry; Metallurgy | 1 | Active |
| US9701746B2 | Methods of treating neuropathic pain with specific binding members for NGF | Chemistry; Metallurgy | 0 | Active |
| US10077305B2 | Antibodies against PD-1 and uses thereof | Physics | 0 | Active |
| US12391768B2 | Antibodies to ticagrelor and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12065496B2 | Antibody molecules and conjugates | Chemistry; Metallurgy | 0 | Active |
| US11078284B2 | Antibodies specific for LOX1 and use in treatment of cardiovascular disorders | Physics | 0 | Active |
| US10329345B2 | Stabilized angiopoietin-2 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10117889B2 | Antibodies specific for LOX1 and use in treatment of cardiovascular disorders | Physics | 0 | Active |
| US8288123B2 | Methods and means relating to protein variants | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.